BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7778179)

  • 1. Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation.
    Ok E; Akçiçek F; Töz H; Kürşat S; Töbü M; Başçi A; Mees EJ
    Transplantation; 1995 Jun; 59(11):1623-6. PubMed ID: 7778179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of posttransplant erythrocytosis with enalapril.
    Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
    Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
    Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
    Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
    Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
    Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
    Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
    Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
    Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency--an underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: risks and effects of ACEI and of iron treatment.
    Jimeno L; Rodado R; Campos M; Lanuza M
    Transplant Proc; 2005 Mar; 37(2):1007-8. PubMed ID: 15848606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early posttransplant erythrocytosis in renal allograft recipients.
    Prakash J; Singh S; Behur SK; Ghosh B; Sharatchandra LK; Dwivedi US
    J Assoc Physicians India; 2010 Sep; 58():574-6. PubMed ID: 21391381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
    Gleiter CH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
    Ahmed S; Ahmed E; Naqvi R; Qureshi S
    J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
    Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R; Beeri M; Hubert A; Kramer MR; Matzner Y
    Arch Intern Med; 1997 Jul; 157(13):1474-8. PubMed ID: 9224226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.
    Bakris GL; Sauter ER; Hussey JL; Fisher JW; Gaber AO; Winsett R
    N Engl J Med; 1990 Jul; 323(2):86-90. PubMed ID: 2163024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J
    Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocytosis after renal transplantation. A prospective analysis.
    Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
    ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.